You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-EGFR (phospho Y1068) antibody (ab5644)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab5644? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab5644 has been referenced in 6 publications.

  1. Deng M et al. Effect and risk of AEE788, a dual tyrosine kinase inhibitor, on regeneration in a rat liver resection model. Eur Surg Res 44:82-95 (2010). WB; Rat. PubMed: 20090347
  2. Deng M et al. Effect and risk of AEE788, a dual tyrosine kinase inhibitor, on regeneration in a rat liver resection model. Eur Surg Res 44:82-95 (2010). Rat. PubMed: 20090347
  3. Donovan MJ et al. A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib. Eur J Cancer 45:1518-26 (2009). PubMed: 19272767
  4. Franovic A et al. Human cancers converge at the HIF-2alpha oncogenic axis. Proc Natl Acad Sci U S A 106:21306-11 (2009). WB; Human. PubMed: 19955413
  5. Rothenberg SM et al. Modeling oncogene addiction using RNA interference. Proc Natl Acad Sci U S A 105:12480-4 (2008). WB; Human. PubMed: 18711136
  6. McDermott U et al. Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling. Proc Natl Acad Sci U S A 104:19936-41 (2007). PubMed: 18077425

Publishing research using ab5644? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"